{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:35:48Z","timestamp":1781123748005,"version":"3.54.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Council of Scientific and Industrial Research, New Delhi"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.ejmech.2014.07.006","type":"journal-article","created":{"date-parts":[[2014,7,4]],"date-time":"2014-07-04T00:17:50Z","timestamp":1404433070000},"page":"928-936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Manzamine alkaloids as antileishmanial agents: A review"],"prefix":"10.1016","volume":"97","author":[{"given":"Penta","family":"Ashok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiren","family":"Lathiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sankaranarayanan","family":"Murugesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2014.07.006_bib1","unstructured":"Second WHO Report on Neglected Tropical Diseases. Sustaining the Drive to Overcome the Global Impact of Neglected Tropical Diseases. Available at: http:\/\/www.who.int\/neglected_diseases\/9789241564540\/en (accessed 10.05.14.)."},{"key":"10.1016\/j.ejmech.2014.07.006_bib2","unstructured":"The Sixtieth World Health Assembly Report on Control of Leishmaniasis. Available at: http:\/\/www.who.int\/neglected_diseases\/mediacentre\/WHA_60.13_Eng.pdf (accessed 10.05.14.)."},{"key":"10.1016\/j.ejmech.2014.07.006_bib3","unstructured":"World Health Organization. Fact Sheet, Leishmaniasis. Available at: http:\/\/www.who.int\/mediacentre\/factsheets\/fs375\/en (accessed 13.05.14.)."},{"key":"10.1016\/j.ejmech.2014.07.006_bib4","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1016\/j.bmcl.2013.06.060","article-title":"Design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents","volume":"23","author":"Suryawanshi","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2014.07.006_bib5","unstructured":"World Health Organization. Global Health Observatory (GHO). Available at: http:\/\/www.who.int\/gho\/neglected_diseases\/leishmaniasis\/en (accessed 12.05.14.)."},{"key":"10.1016\/j.ejmech.2014.07.006_bib6","unstructured":"TDR for Research on Diseases of Poverty. Leishmanisis. Available at: http:\/\/www.who.int\/tdr\/diseases-topics\/leishmaniasis\/en (accessed 12.05.14.)."},{"key":"10.1016\/j.ejmech.2014.07.006_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S1473-3099(07)70209-8","article-title":"Cutaneous leishmaniasis","volume":"7","author":"Reithinger","year":"2007","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2014.07.006_bib8","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1016\/j.bmc.2011.05.055","article-title":"Design, synthesis and antileishmanial in\u00a0vitro activity of new series of chalcones-like compounds: a molecular hybridization approach","volume":"19","author":"Barbosa","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.006_bib9","unstructured":"World Health Organization. Leishmaniasis Burden and Distribution. Available on: http:\/\/www.who.int\/leishmaniasis\/burden\/en\/ (accessed 13.05.14.)."},{"key":"10.1016\/j.ejmech.2014.07.006_bib10","unstructured":"Mucocutaneous Leishmaniasis. Stanford University. Available at: http:\/\/www.stanford.edu\/class\/humbio103\/ParaSites2006\/Leishmaniasis\/Mucocutaneous (accessed 12.05.14.)."},{"key":"10.1016\/j.ejmech.2014.07.006_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbrc.2011.11.023","article-title":"A\u00a0novel mechanism for an old drug: amphotericin B in the treatment of visceral leishmaniasis","volume":"416","author":"Chattopadhyay","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2014.07.006_bib12","unstructured":"First WHO Report on Neglected Tropical Diseases. Working to Overcome the Global Impact of Neglected Tropical Diseases. Available at: http:\/\/www.who.int\/neglected_diseases\/2010report\/en (accessed 14.05.14.)."},{"key":"10.1016\/j.ejmech.2014.07.006_bib13","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1111\/j.1365-4632.2010.04558.x","article-title":"Post-kala-azar dermal leishmaniasis \u2013 an overview","volume":"49","author":"Ganguly","year":"2010","journal-title":"Int. J. Dermatol"},{"key":"10.1016\/j.ejmech.2014.07.006_bib14","series-title":"Price, Report of the Fourth TDR\/IDRI Meeting on Second-Generation Vaccines Against Leishmaniasis","author":"Eric Dumonteil","year":"2001"},{"key":"10.1016\/j.ejmech.2014.07.006_bib15","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2014.07.006_bib16","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.4269\/ajtmh.2010.10-0171","article-title":"Lipsosomal Amphotericin B for treatment of cutaneous leishmaniasis","volume":"83","author":"Wortmann","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2014.07.006_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1086\/600105","article-title":"Highly effective oral Amphotericin B formulation against murine visceral leishmaniasis","volume":"200","author":"Wasan","year":"2009","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ejmech.2014.07.006_bib18","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2014.07.006_bib19","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1128\/AAC.00465-07","article-title":"Antileishmanial structure-activity relationships of synthetic phospholipids: in-vitro and in-vivo activities of selected derivatives","volume":"51","author":"Seifert","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2014.07.006_bib20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/jac\/47.5.537","article-title":"Mechanism of action of anti-proliferative lysophospholipid analogues against the protozoan parasite Trypanosoma cruzi: potentiation of in\u00a0vitro activity by the sterol biosynthesis inhibitor ketoconazole","volume":"47","author":"Lira","year":"2001","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2014.07.006_bib21","unstructured":"Guidelines on Use of Oral Drug Miltefosine for the Treatment of Kala-azar in the Endemic States on a Pilot Basis, GovernmentGovernament of India. Available at: http:\/\/www.nvbdcp.gov.in\/Doc\/Guidelines%20on%20miltefosine.pdf (accessed 12.05.14.)."},{"key":"10.1016\/j.ejmech.2014.07.006_bib22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.exppara.2013.08.004","article-title":"Miltefosine resistance in Leishmania donovani involves suppression of oxidative stress-induced programmed cell death","volume":"135","author":"Mishra","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ejmech.2014.07.006_bib23","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1016\/j.bmc.2009.02.050","article-title":"Antimalarials from nature","volume":"17","author":"Kaur","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.006_bib24","doi-asserted-by":"crossref","first-page":"4374","DOI":"10.1021\/jm400053v","article-title":"Discovery of a new class of natural product-inspired quinazolinone hybrid as potent antileishmanial agents","volume":"56","author":"Sharma","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.006_bib25","first-page":"7","article-title":"Synthetic and natural products against leishmaniasis: a review","volume":"1","author":"Rajeshree","year":"2012","journal-title":"World J. Public Health Sci."},{"key":"10.1016\/j.ejmech.2014.07.006_bib26","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1021\/ja981303k","article-title":"The first total syntheses of ircinol A, ircinal A, and manzamines A and D","volume":"120","author":"Winkler","year":"1998","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2014.07.006_bib27","doi-asserted-by":"crossref","first-page":"6404","DOI":"10.1021\/ja00280a055","article-title":"Manzamine A, a novel antitumor alkaloid from a sponge","volume":"108","author":"Sakai","year":"1986","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2014.07.006_bib28","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.1016\/S0040-4020(98)00357-3","article-title":"Manzamine alkaloids, syntheses and synthetic approaches","volume":"54","author":"Magnier","year":"1998","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2014.07.006_bib29","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4161\/cc.20135","article-title":"Manzamines: a potential for novel cures","volume":"11","author":"Radwan","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmech.2014.07.006_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1021\/jm900672t","article-title":"Structure-activity relationship and mechanism of action studies of manzamine analogues for the control of neuroinflammation and cerebral infections","volume":"53","author":"Peng","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.006_bib31","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1021\/np060092r","article-title":"Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure\u2013activity relationship (SAR) studies of the manzamine alkaloids. potential for Alzheimer's disease","volume":"70","author":"Hamann","year":"2007","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2014.07.006_bib32","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1128\/AAC.44.6.1645-1649.2000","article-title":"In-vivo antimalarial activity of the beta-carboline alkaloid manzamine A","volume":"44","author":"Ang","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2014.07.006_bib33","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.1016\/j.bmc.2008.05.079","article-title":"2-N-methyl modifications and SAR studies of manzamine A","volume":"16","author":"Ibrahim","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.006_bib34","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1021\/np020592u","article-title":"New manzamine alkaloids with activity against infectious and tropical parasitic diseases from an Indonesian sponge","volume":"66","author":"Rao","year":"2003","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2014.07.006_bib35","doi-asserted-by":"crossref","first-page":"8584","DOI":"10.1021\/ja0202964","article-title":"Enantioselective total syntheses of manzamine a and related alkaloids","volume":"124","author":"Humphrey","year":"2002","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2014.07.006_bib36","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0040-4039(00)95796-4","article-title":"Keramamine-A and -B, novel antimicrobial alkaloids from the okinawan marine sponge Pellina sp","volume":"28","author":"Nakamura","year":"1987","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2014.07.006_bib37","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1016\/S0040-4039(00)96762-5","article-title":"Manzamine B and C, two novel alkaloids from the sponge Haliclona sp","volume":"28","author":"Sakai","year":"1987","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2014.07.006_bib38","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1016\/0040-4039(88)85091-3","article-title":"New manzamine alkaloids from a sponge of the genus Xestospongia","volume":"29","author":"Ichiba","year":"1988","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2014.07.006_bib39","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1021\/jo00034a052","article-title":"Ircinals A and B from the okinawan marine sponge Ircinia sp.: plausible biogenetic precursors of manzamine alkaloids","volume":"57","author":"Kondo","year":"1992","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2014.07.006_bib40","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1021\/np50103a027","article-title":"8-hydroxymanzamine A, a \u03b2-carboline alkaloid from a sponge, Pachypellina sp","volume":"57","author":"Ichiba","year":"1994","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2014.07.006_bib41","doi-asserted-by":"crossref","first-page":"13567","DOI":"10.1016\/S0040-4020(01)85671-4","article-title":"1,2,3,4-Tetrahydro-8-hydroxymanzamines, alkaloids from two different haplosclerid sponges","volume":"50","author":"Crews","year":"1994","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2014.07.006_bib42","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1021\/np50114a021","article-title":"6-Hydroxymanzamine A and 3,4-dihydromanzamine a, new alkaloids from the okinawan marine sponge Amphimedon sp","volume":"57","author":"Kobayashi","year":"1994","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2014.07.006_bib43","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1016\/S0040-4039(00)73363-6","article-title":"Keramaphidin C and keramamine C plausible biogenetic precursors of manzamine C from an okinawan marine sponge","volume":"35","author":"Tsuda","year":"1994","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2014.07.006_bib44","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1016\/0040-4020(95)95723-9","article-title":"Four new \u03b2-carboline alkaloids isolated from two okinawan marine sponges of Xestospongia sp. and Haliclona sp","volume":"51","author":"Kobayashi","year":"1995","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2014.07.006_bib45","doi-asserted-by":"crossref","first-page":"10743","DOI":"10.1021\/ja00148a017","article-title":"Kauluamine, an unprecedented manzamine dimer from an Indonesian marine sponge, Prianos sp","volume":"117","author":"Ohtani","year":"1995","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2014.07.006_bib46","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/0040-4020(95)01057-2","article-title":"Chiral resolution of (\u00b1)-keramaphidin B and isolation of manzamine L, a new \u03b2-carboline alkaloid from a sponge Amphimedon sp","volume":"52","author":"Tsuda","year":"1996","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2014.07.006_bib47","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1021\/np9604083","article-title":"Four new bioactive manzamine-type alkaloids from the philippine marine sponge Xestospongia ashmorica","volume":"59","author":"Edrada","year":"1996","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2014.07.006_bib48","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1021\/np970564p","article-title":"Three new manzamine congeners from Amphimedon sponge","volume":"61","author":"Watanabe","year":"1998","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2014.07.006_bib49","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0040-4039(97)10842-5","article-title":"Ma'eganedin A, a new manzamine alkaloid from Amphimedon sponge","volume":"39","author":"Tsuda","year":"1998","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2014.07.006_bib50","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1016\/S0040-4020(00)00534-2","article-title":"New cytotoxic manzamine alkaloids from a palaun sponge","volume":"56","author":"Zhou","year":"2000","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2014.07.006_bib51","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1021\/ja002073o","article-title":"New manzamine alkaloids with potent activity against infectious diseases","volume":"123","author":"El Sayed","year":"2001","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2014.07.006_bib52","doi-asserted-by":"crossref","first-page":"7397","DOI":"10.1016\/S0040-4020(02)00825-6","article-title":"12,34-Oxamanzamines, novel biocatalytic and natural products from manzamine producing Indo-Pacific sponges","volume":"58","author":"Yousaf","year":"2002","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2014.07.006_bib53","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1021\/jm030475b","article-title":"New manzamine alkaloids from an indo-pacific sponge. pharmacokinetics, oral availability, and the significant activity of several manzamines against HIV-I, AIDS opportunistic infections, and inflammatory diseases","volume":"47","author":"Yousaf","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2014.07.006_bib54","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1021\/np0400095","article-title":"Three new manzamine alkaloids from a common Indonesian sponge and their activity against infectious and tropical parasitic diseases","volume":"67","author":"Rao","year":"2004","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2014.07.006_bib55","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1021\/np0601399","article-title":"Manzamine B and E and Ircinal A related alkaloids from an Indonesian Acanthostrongylophora sponge and their activity against infectious, tropical parasitic, and alzheimer's diseases","volume":"69","author":"Rao","year":"2006","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2014.07.006_bib56","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.tet.2009.01.032","article-title":"Zamamidine C, 3,4-dihydro-6-hydroxy-10,11-epoxymanzamine A, and 3,4-dihydromanzamine J N-oxide, new manzamine alkaloids from sponge Amphimedon sp","volume":"65","author":"Yamada","year":"2009","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2014.07.006_bib57","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.1016\/j.tetlet.2012.08.140","article-title":"Acantholactone, a new manzamine related alkaloid with an unprecedented \u03b4-lactone and \u03b5-lactam ring system","volume":"53","author":"Wahba","year":"2012","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2014.07.006_bib58","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1021\/np800163u","article-title":"Kinetic studies and Bioactivity of potential manzamine Prodrugs","volume":"71","author":"Shilabin","year":"2008","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2014.07.006_bib59","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1021\/jm00126a021","article-title":"Hybrid molecules: growth inhibition of Leishmania donovani promastigotes by thiosemicarbazones of 3-carboxy-\u03b2-carbolines","volume":"32","author":"Dodd","year":"1989","journal-title":"J.\u00a0Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414006126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523414006126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T22:55:58Z","timestamp":1538434558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523414006126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":59,"alternative-id":["S0223523414006126"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.07.006","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Manzamine alkaloids as antileishmanial agents: A review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2014.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}